The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro-Reference-Cited by-同舟云学术

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro

Published:2017-06-20 Issue:1 Volume:1 Page:49-56
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Schultz Nina H.¹²³⁴,Tran Hoa T. T.¹³,Bjørnsen Stine¹,Henriksson Carola E.⁴⁵,Sandset Per M.¹²⁴^ORCID,Holme Pål A.¹²⁴

Affiliation:

1. Research Institute of Internal Medicine; Oslo University Hospital; Oslo Norway

2. Department of Haematology; Oslo University Hospital; Oslo Norway

3. Department of Haematology; Akershus University Hospital; Lørenskog Norway

4. Institute of Clinical Medicine; University of Oslo; Oslo Norway

5. Department of Medical Biochemistry; Oslo University Hospital; Oslo Norway

Funder

Bayer

Publisher

Wiley

Subject

Hematology

Reference37 articles.

1. Oral apixaban for the treatment of acute venous thromboembolism;Agnelli;N Engl J Med,2013

2. Overview of the new oral anticoagulants: opportunities and challenges;Yeh;Arterioscler Thromb Vasc Biol,2015

3. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

4. The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis;Chai-Adisaksopha;Blood,2014

5. A meta-analysis of randomized controlled trials of the risk of bleeding with apixaban versus vitamin K antagonists;Touma;Am J Cardiol,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FEIBA: Too Potent a Potion or Just Right for Post-CPB Bleeding?;Journal of Cardiothoracic and Vascular Anesthesia;2024-09

2. Reversal of pre-injury factor-Xa inhibitors with prothrombin complex concentrates in patients following traumatic brain injury;Clinical Neurology and Neurosurgery;2023-12

3. Administration of andexanet alfa for traumatic intracranial hemorrhage in the setting of massive apixaban overdose: A case report;American Journal of Health-System Pharmacy;2023-09-09

4. DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature;Journal of Thrombosis and Haemostasis;2023-03

5. In Vitro Apixaban Removal By CytoSorb Whole Blood Adsorber: An Experimental Study;Journal of Cardiothoracic and Vascular Anesthesia;2022-06